1. Home
  2. CNTB vs ABVE Comparison

CNTB vs ABVE Comparison

Compare CNTB & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • ABVE
  • Stock Information
  • Founded
  • CNTB 2012
  • ABVE 2019
  • Country
  • CNTB United States
  • ABVE Canada
  • Employees
  • CNTB N/A
  • ABVE N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • ABVE Packaged Foods
  • Sector
  • CNTB Health Care
  • ABVE Consumer Staples
  • Exchange
  • CNTB Nasdaq
  • ABVE Nasdaq
  • Market Cap
  • CNTB 68.5M
  • ABVE 21.3M
  • IPO Year
  • CNTB 2021
  • ABVE N/A
  • Fundamental
  • Price
  • CNTB $1.17
  • ABVE $0.57
  • Analyst Decision
  • CNTB Strong Buy
  • ABVE
  • Analyst Count
  • CNTB 1
  • ABVE 0
  • Target Price
  • CNTB $8.00
  • ABVE N/A
  • AVG Volume (30 Days)
  • CNTB 24.6K
  • ABVE 45.2K
  • Earning Date
  • CNTB 09-05-2024
  • ABVE 11-15-2024
  • Dividend Yield
  • CNTB N/A
  • ABVE N/A
  • EPS Growth
  • CNTB N/A
  • ABVE N/A
  • EPS
  • CNTB N/A
  • ABVE N/A
  • Revenue
  • CNTB $24,116,000.00
  • ABVE $275,376,450.00
  • Revenue This Year
  • CNTB N/A
  • ABVE N/A
  • Revenue Next Year
  • CNTB $63.90
  • ABVE N/A
  • P/E Ratio
  • CNTB N/A
  • ABVE N/A
  • Revenue Growth
  • CNTB N/A
  • ABVE N/A
  • 52 Week Low
  • CNTB $0.68
  • ABVE $0.47
  • 52 Week High
  • CNTB $2.84
  • ABVE $9.48
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 44.02
  • ABVE N/A
  • Support Level
  • CNTB $1.18
  • ABVE N/A
  • Resistance Level
  • CNTB $1.26
  • ABVE N/A
  • Average True Range (ATR)
  • CNTB 0.07
  • ABVE 0.00
  • MACD
  • CNTB -0.01
  • ABVE 0.00
  • Stochastic Oscillator
  • CNTB 13.59
  • ABVE 0.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world — one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: